2076
T. Tanahashi et al. / Phytochemistry 70 (2009) 2072–2077
4.5. (200S)-10-hydroxy-200-methoxyoleuropein (2)
3. Concluding remarks
Colorless amorphous powder, ½a D28
ꢂ
-109 (c 0.3, MeOH); UV k
MeOH
max
Oleoside type secoiridoid glucosides have been isolated from L.
vulgare, while 10-hydroxyoleoside type secoiridoid glucosides
were obtained as main constituents along with their structurally
related unique secoiridoids in the present study.
cmꢀ1: 3389,
KBr
nm (log
e
): 202 (4.61), 232 (4.21), 281 (3.48); IR
m
max
1734, 1705, 1636, 1439, 1286, 1078; For 1H and 13C NMR spectro-
scopic data, see Table 1; HMBC: H-1?C-8, 10, H-3?C-1, 4, 5, 11, H-
5?C-4, 6, 7, 8, 9, H2-6?C-7, H2-10?C-8, 9, H-10?C-1, H2-100?C-7,
300, H2-200?C-100, 400, 800, H-400?C-300, 500, 600, H-700?C-300, 500, 600, 800,
11-OMe?C-11, 200-OMe?C-200; HR-SIMS Found: 585.1841 [M-
H]ꢀ; C26H33O15 requires 585.1820.
4. Experimental
4.1. General
1H (500 MHz) and 13C (125 MHz) NMR: TMS as int. standard.
SIMS: glycerol or 3-nitrobenzyl alcohol as matrix. TLC: silica gel.
4.6. Ligustrohemiacetal A (3)
Colorless amorphous powder, ½a D21
ꢂ
+ 169 (c 0.1, MeOH); UV
MeOH
max
cmꢀ1: 3452, 1734, 1705,
KBr
k
nm (log
e
): 236 (3.98); IR
m
max
4.2. Plant material
1630, 1088; For 1H NMR and 13C NMR spectroscopic data, see Ta-
bles 2 and 3; HMBC: H-1?C-10, H-3?C-4, 5, 8, H-6 (d 3.18) ?C-
4, H2-6?C-5, 7, 9, H-10 (d 3.93) ?C-1, 9, H2-10?C-8, 7-OMe?C-
7, 11-OMe?C-11; HR-EIMS Found: 272.0904 [M]+; C12H26O7 re-
quires 272.1000.
The leaves and twigs of L. vulgare L. were collected at Kameoka
Park in Kyoto Prefecture, Japan. A voucher specimen (02059) was
deposited in the laboratory of Nippon Shinyaku Institute for Botan-
ical Research.
4.7. Ligustrohemiacetal B (4)
4.3. Isolation of compounds
Colorless amorphous powder, ½a D21
ꢂ
+ 179 (c 0.1, MeOH); UV
nm (log e): 226 (4.13), 231 (4.08), 277 (3.23), 288 (2.97); IR
Dried leaves and twigs of L. vulgare (2.14 kg) were extracted
with MeOH (18L ꢁ 3) under conditions of reflux. After concentra-
tion, the extract (29.9 g) was suspended in H2O and filtered
through a Celite layer. The filtrate and washings were combined
and extracted successively with CHCl3 and n-BuOH. The CHCl3 ex-
tract (2.5 g) was applied to a silica gel column. Elution with MeOH–
CHCl3 mixtures gave 3 fractions, C-I (1% MeOH–CHCl3, 78 mg), C-II
(3% MeOH–CHCl3, 79 mg), and C-III (3–10% MeOH–CHCl3, 313 mg).
Fractions C-I–C-III were further purified by prep. HPLC
MeOH
max
KBr
k
m
cmꢀ1: 3430, 1701, 1630, 1518, 1286, 1204, 1088; For 1H
max
NMR and 13C NMR spectroscopic data, see Tables 2 and 3; HMBC:
H-1?C-9, 10, H-3?C-4, 8, 11, H2-6?C-4, 5, 7, 9, H2-10?C-8, 11-
OMe?C-11, H2-10?C-7, H2-20?C-1’, H-40, 80?C-20, 30, 5’, 6’, H-50,
7’?C-4’, 6’; HR-CIMS Found: 379.1398 [M + H]+; C19H23O8 requires
379.1394.
(lBondasphere 5l C18-100 Å, H2O–MeOH, 3:2 or H2O–MeCN,
4.8. Methylation of 1 and 2 followed by Methanolysis
3:2, 7:3) and prep. TLC (CHCl3–MeOH–AcOH, 16:4:1 or
acetone–CHCl3–H2O, 8:2:1). Fr. C-I: 4 (2.7 mg); fr. C-II: 1-O-trans-
cinnamoyl-b-D-glucopyranose (2.3 mg); fr. C-III: ligstroside
(3.8 mg), 10-hydroxyligstroside (7) (3.2 mg). The n-BuOH extract
(9.7 g) was applied to a Wakogel LP-40C18 (Wako Pure Chemical
Industries, Ltd., Osaka, Japan) column. Elution with MeOH–H2O
mixtures gave 4 fractions, B-I (1–3% MeOH in H2O, 191 mg), B-II
(10–20% MeOH in H2O, 632 mg), B-III (20–30% MeOH in H2O,
1.65 g), and B-IV (30–40% MeOH in H2O, 1.03 g). Fractions B-I–B-
A solution of a mixture of 1 and 2 (1:4, 1 mg) in MeOH (1 ml)
was treated with CH2N2–Et2O under ice-cooling. The reaction mix-
ture was concentrated and dried in vacuo, then the residue was dis-
solved in dry MeOH (1 ml) and 0.1 M NaOMe (1 ml). The solution
was stirred at room temperature for 1 h. After neutralization with
Amberlite IR-120 (H+-form), the reaction mixture was extracted
with CHCl3. The CHCl3 layer was concentrated to give 11, which
was identified as 2-methoxy-2-(3,4-dimethoxyphenyl)ethanol
(1H NMR, EI-MS). HPLC analysis using a chiral HPLC [column: CHI-
RALCEL OB-H (4.6 mm i.d. ꢁ 250 mm, Daicel Chemical Industries,
Ltd.); mobile phase: n-hexane-2-propanol (22:3)] demonstrated
that the product contained (R)- and (S)-2-methoxy-2-(3,4-dime-
thoxyphenyl)ethanols in the ratio of 1:4.
IV were further purified by prep. HPLC (lBondasphere 5l C18-
100 Å, H2O–MeOH, 7:3, 63:37, 3:2, 11:9, 1:1 or H2O–MeCN, 4:1)
and prep. TLC (CHCl3–MeOH, 7:3, CHCl3–MeOH–AcOH, 16:4:1 or
acetone–CHCl3–H2O, 8:2:1). Fr. B-I: 3,4-dihydroxyphenethyl alco-
hol (8.6 mg); fr. B-II: p-hydroxyphenethyl alcohol (11 mg), 10-
hydroxyoleoside dimethyl ester (8) (8.8 mg), secologanoside
(10 mg);
fr.
B-III:
1-O-trans-cinnamoyl-b-D-glucopyranose
(3.8 mg),
-L-rhamno-
(37 mg), 10-hydroxyoleuropein (6) (320 mg),
(5.9 mg), 3 (2.5 mg); fr. B-IV: kaempferol 3,7-O-bis-
1
2
4.9. Enzymatic hydrolysis of 6
a
pyranoside (26 mg).
b-Glucosidase (Wako, 10 mg, 368 U) was added to a solution of
6 (80 mg) in 0.2 M acetate buffer (pH 5.2, 2 ml). After being kept at
37ꢀC for 12 h, the reaction mixture was diluted with H2O and ex-
tracted with EtOAc. The EtOAc extract was concentrated in vacuo,
and the residue was purified by prep. HPLC (H2O-MeOH, 1:1) to
4.4. (200R)-10-hydroxy-200-methoxyoleuropein (1)
Colorless amorphous powder, ½a D28
ꢂ
– 141 (c 0.3, MeOH); UV
): 202 (4.64), 232 (4.19), 281 (3.47); IR
k
nm (log
e
m
cmꢀ1
:
give 14 (22.3 mg) as an oil. 14: ½a D21
ꢂ
+ 163 (c 0.88, MeOH). IR mmax
MeOH
max
KBr
max
3368, 1734, 1701, 1630, 1439, 1288, 1202, 1089; For 1H and 13C
NMR spectroscopic data, see Table 1; HMBC: H-1?C-8, 10, H-
3?C-1, 4, 5, 11, H-5?C-4, 6, 7, 8, 9, H2-6?C-7, H2-10?C-8, 9, H-
10?C-1, H2-100?C-7, 300, H2-200?C-100, 400, 800, H-400?C-300, 500, 600,
H-700?C-300, 500, 600, 800, 11-OMe?C-11, 200-OMe?C-200; HR-SIMS
Found: 585.1799 [M-H]ꢀ; C26H33O15 requires 585.1820.
cmꢀ1: 3410, 1705, 1628, 1522, 1286, 1192, 1088. For 1H NMR
and 13C NMR, spectroscopic data, see Tables 2 and 3. HMBC: H-
1?C-9, 10, H-3?C-4, 8, 11, H2-6?C-4, 5, 7, 9, H2-10?C-1, 8, 11-
OMe?C-11, H2-10?C-7, H2-20?C-10, 30, H-40?C-20, 30, 50, 80, H-
80?C-20, 40. NOESY: H-8/H-5, H-9/H-10 (d 4.09). HR-SIMS Found:
395.1345 [M + H]+; C19H23O9 requires 395.1343.